Using Medical IP's AI and 3D medical image technology, our university has developed 3D digital anatomical education content for medical students, advancing toward a new era of metaverse anatomy education. We had the opportunity to compare technologies from various companies, and in terms of developing innovative educational content, Medical IP's products offered the most effective solution. Their technology was the most agile and flexible in innovating existing software and hardware, aligning with our vision to transform anatomy education into a metaverse-based learning experience. This collaboration allowed us to offer students the most groundbreaking medical education program, incorporating immersive 3D virtual reality anatomy dissection. We are leading a paradigm shift in anatomy education, integrating these technologies to establish a metaverse platform. We have collaborated with Medical IP and published several scientific papers in leading journals. Our randomized control study showed that virtual anatomy dissection's educational efficacy and satisfaction were superior to traditional cadaver anatomy dissection in a subgroup of students. We are committed to generating robust evidence supporting the educational effectiveness of this immersive 3D digital content.

Medical IP’s virtual anatomy table is revolutionizing the field of anatomical education. This technology provides highly accurate 3D images that closely align with real anatomical structures, enabling students to intuitively understand the complexities of the human body. Traditional anatomy education often faces limitations due to time and resource constraints, but Medical IP’s solution overcomes these barriers, offering immersive learning experiences anytime and anywhere. Notably, by providing virtual cases such as fetuses and pregnant women, students can study anatomy in various scenarios without the need for actual cadavers. I am confident that Medical IP’s technology will become a core asset for future medical education and research, making a significant contribution to the advancement of anatomy.

Medical IP has various driving forces to visually implement the blueprint of the future medical field. Although there have been many difficulties, we have successfully established a clinical application platform for a patient-specific 3D brain disease model in the neurosurgery field and are in the standardization stage. Now, based on this track record, they are expanding into the AR/VR field. The ongoing process of developing a brain tumor diagnosis system based on AI technology brings me great joy and anticipation about the future that the result will bring to the medical field.

Robotic partial nephrectomy for removal of kidney cancer performed along with MEDICAL IP’s 3D kidney surgical simulator was full of wonders for me. The simulators were similar not only in shape but also in texture and material to the real human organ and this let patients who witnessed their patient-specific 3D kidney models get a better understanding of their tumor. With the excellent 3D kidney surgical simulators provided by MEDICAL IP, we confirmed the successful clinical results and were able to publish these results. I am happy and grateful now that MEDICAL IP is making contributions for patients suffering from kidney cancer. I wish to continue this enjoyable journey with this company.